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Store operated calcium entry (SOCE) is a principal
cellular process by which cells regulate basal
calcium, refill intracellular Ca2+ stores, and execute
a wide range of specialized activities. STIM and
Orai proteins have been identified as the essential
components enabling the reconstitution of Ca2+
release-activated Ca2+ (CRAC) channels that me-
diate SOCE. Here, we report the molecular identifica-
tion of SARAF as a negative regulator of SOCE.
Using heterologous expression, RNAi-mediated
silencing and site directed mutagenesis combined
with electrophysiological, biochemical and imaging
techniques we show that SARAF is an endoplasmic
reticulummembrane resident protein that associates
with STIM to facilitate slow Ca2+-dependent inactiva-
tion of SOCE. SARAF plays a key role in shaping
cytosolic Ca2+ signals and determining the content
of the major intracellular Ca2+ stores, a role that is
likely to be important in protecting cells from Ca2+
overfilling.
INTRODUCTION
Store operated calcium entry (SOCE) represents a key mecha-
nism, by which cells convey Ca2+ signals and maintain Ca2+
homeostasis (Parekh and Putney, 2005). Despite its initial
characterization more than two decades ago, when SOCE was
characterized mainly via mechanistic and biophysical means,
only recently have the molecular components essential for its
activity been identified. The molecular identification revealed
the discrete events associated with SOCE activation and regula-
tion (Cahalan, 2009; Lewis, 2007; Putney, 1986). STIM and Orai
proteins are the essential components that enable the reconsti-
tution of Ca2+ release-activated Ca2+ (CRAC) channels under-
lying SOCE activity (Feske et al., 2006; Liou et al., 2005; Peinelt
et al., 2006; Prakriya et al., 2006; Roos et al., 2005; Soboloff
et al., 2006; Vig et al., 2006; Zhang et al., 2006; Zhang et al.,
2005). Although other proteins, such as members of the TRPCfamily, might also be involved in SOCE (Hardie and Minke,
1993; Kiselyov et al., 1998; Liu et al., 2007; Pani et al., 2009),
STIM, the Ca2+ sensor (Liou et al., 2005; Roos et al., 2005;
Stathopulos et al., 2008; Zhang et al., 2005), and Orai, the
channel pore forming subunit (Prakriya et al., 2006; Vig et al.,
2006; Yeromin et al., 2006), have been shown to be sufficient
for this activity. STIM is an endoplasmic reticulum (ER) single
pass membrane protein (Hogan et al., 2010), which detects
changes in ER Ca2+ levels through a conserved Ca2+ binding
domain (EF hand) (Stathopulos et al., 2009; Stathopulos et al.,
2008). ER Ca2+ depletion leads to STIM oligomerization and
relocalization to specialized regions close to the plasma
membrane (ER-PM junctions), where it directly binds to Orai,
causing the opening of the channel and initiation of Ca2+ entry
(Baba et al., 2006; Barr et al., 2008; Frischauf et al., 2009; Kawa-
saki et al., 2009; Liou et al., 2007; Liou et al., 2005; Muik et al.,
2008; Navarro-Borelly et al., 2008; Park et al., 2009; Wu et al.,
2006; Yuan et al., 2009; Zhang et al., 2005; Zhou et al., 2010).
Once SOCE is activated, it is subjected to various direct and
indirect regulatory processes that determine the duration and
magnitude of the Ca2+ influx, which set downstream cellular
events (Hogan et al., 2010; Parekh and Putney, 2005). Two defin-
itive Ca2+-dependent modes of regulation of CRAC channels
were previously reported: fast inactivation that depends largely
on STIM1 and calmodulin binding to Orai1 (Derler et al., 2009;
Hoth and Penner, 1993; Lee et al., 2009; Litjens et al., 2004;
Mullins et al., 2009) and a slow Ca2+-dependent inactivation
process with an unknown molecular mechanism (Louzao et al.,
1996; Parekh, 1998; Zweifach and Lewis, 1995).
Using a functional-based high-throughput screen, we have
identified the gene product of TMEM66, named hereafter as
SARAF (for SOCE-associated regulatory factor) as a regulator
of cellular Ca2+ homeostasis. SARAF is a highly conserved
protein in vertebrates and has poor functional annotation. In
mammals, SARAF is ubiquitously expressed but has exception-
ally high transcript levels in the immune and neuronal tissues
(Su et al., 2004). In this study we show that SARAF is an ER resi-
dent protein, which responds to cytosolic Ca2+ elevation after
ER Ca2+ refilling by promoting a slow inactivation process of
STIM2-dependent basal SOCE activity, as well as STIM1-medi-
ated SOCE activity. These actions collectively impose stringent
conditions for maintaining proper intracellular Ca2+ levels in
both resting and stimulated cells.Cell 149, 425–438, April 13, 2012 ª2012 Elsevier Inc. 425
RESULTS
SARAF Regulates Basal ER and Cytosolic Ca2+ Levels
We performed a functional expression screen in an attempt to
isolate cDNA candidates that affect mitochondrial Ca2+ homeo-
stasis (Figures S1A and S1B, available online). These efforts lead
to the identification of a 2 kilobase cDNA clone with a 1020 bp
open reading frame coding for SARAF (accession #JQ348891)
(also known as TMEM66, XTP-3, FOAP-7, HSPC035,
MGC8721 or FLJ22274) (Figure 1A). Transfection of HEK293
cells with SARAF cDNA alone resulted in lowered basal mito-
chondrial Ca2+ levels compared to control cells (Figures S1A
and S1B).
Because changes in basal mitochondrial Ca2+ levels may
reflect changes in global cellular Ca2+ homeostasis, we also
tested the effect of SARAF expression on cytosolic and ER
Ca2+ levels. These parameters were measured with a fura-2 or
FRET-based D1ER indicator (Palmer et al., 2004), respectively.
Transfection of HeLa or HEK293-T cells with SARAF cDNA, or
with an empty vector (control), showed that basal [Ca2+]ER was
significantly decreased in SARAF-overexpressing cells (Fig-
ure 1B). In order to assess the relationship between SARAF
expression levels and [Ca2+]cyto, we expressed SARAF C termi-
nally tagged with yellow fluorescent protein (YFP) (SARAF-YFP)
or YFP (control), and measured [Ca2+]cyto as a function of protein
expression, as judged by YFP fluorescence. We found that
decreased [Ca2+]cyto highly correlated with YFP fluorescence in
cells expressing SARAF-YFP but not in cells expressing YFP
alone (Figure 1C), indicating that SARAF expression primarily
affected global Ca2+ homeostasis. In order to assess the role
of endogenous SARAF expression, a siRNA silencing approach
against SARAFwas used in bothHeLa and Jurkat cells. Reduced
expression of SARAF resulted in a significant elevation of basal
[Ca2+]cyto in both cell types (Figures 1D–1F). Likewise, [Ca
2+]ER
levels, estimated by organelle content release using ionomycin
(Brandman et al., 2007) or with the D1ER indicator, were higher
in siRNA-treated cells, (Figure 1F inset and Figure S1D). The
specificity and efficiency of siRNA-mediated silencing of SARAF
mRNA and protein levels were determined by western blotting,
semiquantitative RT-PCR, and a fluorescent-based assay em-
ploying YFP fluorescence as reference for protein expression
(Figure 1D and Figure S2). The functionality of SARAF-YFP sug-
gested that the protein is correctly expressed and folded and
therefore encouraged us to study its cellular localization. When
a fluorescent-tagged chimera of SARAF was coexpressed with
either that of STIM1 or SEC61, both ER resident proteins, SARAF
fluorescence strongly overlapped with both markers (Figure 1G
and Figure S1E), but did not colocalize with that of mitochondrial
markers (data not shown), indicating that the ER is the primary
site for SARAF subcellular localization.
At resting conditions, SARAF modulation of [Ca2+]i must
involve a change of Ca2+ fluxes at the level of the plasma
membrane (Rı´os, 2010). This can be achieved either through
the regulation of plasma membrane Ca2+ permeation or extru-
sion pathways. In order to distinguish between these two possi-
bilities, we overexpressed SARAF in HEK293-T or HeLa cells
and tested whether SARAF-mediated reduction of [Ca2+]cyto de-
pended on the presence of Ca2+ in the growth media. Control426 Cell 149, 425–438, April 13, 2012 ª2012 Elsevier Inc.and SARAF overexpressing cells grown on a low Ca2+-contain-
ing media (0.1 mM), exhibited similar cytosolic Ca2+ levels (Fig-
ure S1C), suggesting that increased SARAF expression is linked
to inhibition of Ca2+ entry from an extracellular source rather than
the activation of a Ca2+-extrusion mechanism. Recent findings
by Meyer and colleagues showed that STIM2 plays a central
role in maintaining basal [Ca2+]cyto and [Ca
2+]ER by acting as
a feedback regulator that senses small changes in ER Ca2+
and translates them into differential gating of Orai1 (Brandman
et al., 2007). To test whether SARAF regulation of basal [Ca2+]cyto
is linked to the STIM2-Orai1 pathway, we used siRNA-mediated
knock down of STIM2, either alone, or together with SARAF, and
determined basal [Ca2+]cyto in HeLa cells. In agreement with
previous studies (Bird et al., 2009; Brandman et al., 2007), we
observed a significant decrease in [Ca2+]cyto after STIM2
silencing, compared to control (Figure 1H). More importantly,
silencing both STIM2 and SARAF did not result in an additive
effect on resting [Ca2+]cyto. These results suggest that SARAF,
with STIM2, may act on a similar Ca2+ permeation pathway.
SARAF Regulates STIM1-Orai1-Mediated Store
Operated Calcium Entry
STIM2 andSTIM1 sharemoderate sequence similarity andmain-
tain similar domain architecture (Hogan et al., 2010). To test
whether SARAF regulates STIM1-Orai1-mediated SOCE, we
heterologously expressed STIM1 and Orai1 alone or with SARAF
in HEK293 or HEK293-T cells and measured ICRAC, with the
whole-cell variation of the patch clamp technique by passively
depleting Ca2+ from the ER by using ethylene glycol-bis(2-ami-
noethylether)-N,N,N0,N0-tetraacetic acid (EGTA) (1.2 mM) in the
recording pipette (Zweifach and Lewis, 1995). After 3 min under
whole-cell configuration in zero extracellular Ca2+, addition of
10 mM Ca2+ to the bath solution initiated La3+-sensitive strong
inwardly rectifying currents typical of ICRAC (Figures S2A and
S2B). These had similar magnitudes in both control- expressing
(HEK293 22.6 ± 2 pA/pF and HEK239-T 40.7 ± 3.5 pA/pF) and
SARAF- expressing (HEK293 27.1 ± 6pA/pF and HEK293-T
41.8 ± 3.3 pA/pF) cells. Strikingly, we found clear differences in
current inactivation. In control HEK293 cells, currents partially
inactivated to steady-state levels (35.6% ± 3.2% of peak levels),
whereas in SARAF-expressing cells, the extent of current
inactivation was greatly increased (17.3% ± 1% of peak levels,
Figure 2A). An additional period of passive store depletion,
when no external Ca2+ was present, partially restored ICRAC in
control cells (46.5% ± 4.7% of peak levels), whereas in
SARAF-expressing cells, currents remained inactivated (21% ±
3% of peak levels). These results indicate that part of the
SARAF-mediated ICRAC inhibition does not require the contin-
uous presence of elevated Ca2+. Similar results were also
obtained from HEK293-T cells under the same experimental
conditions (Figures S3A and S3B). Intriguingly, a similar ‘‘slow
inactivation’’ process of native ICRAC currents in Jurkat
T-lymphocytes and RBL cells has been observed (Parekh,
1998; Zweifach and Lewis, 1995); however, the molecular
component responsible for this process remained unknown.
The continuous nature of the SARAF-mediated ICRAC inhibition
suggests that inhibition may be Ca2+ dependent. We therefore
performed similar experiments as described above using the
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Figure 1. SARAF Regulates Basal Cytosolic and ER Ca2+ Concentrations by Inhibiting STIM2-Dependent Basal SOCE
(A) The predicted topology and domain structure of the human SARAF. Human SARAF has 339 amino acids with a validated signal peptide (S.Pep) (1–30
[Zhang and Henzel, 2004]) and a putative single membrane spanning domain (173–195, predicted by the SOSUI program). Initiation point of SARAF short isoform
is indicated (aa 173). Also marked are clusters of serine/proline (284–310) and arginine rich regions.
(B) ER Ca2+ levels were measured in control and heterologously expressing SARAF cells, together with D1ER. Averaged D1ER emission ratios from individual
cells are shown (HEK293-T [control, n = 76; SARAF, n = 86], HeLa [control, n = 71; SARAF n = 61]).
(C) Cytosolic Ca2+ levels and YFP expression were measured in HEK293-T cells transfected with SARAF-YFP or YFP (control). Expression units that cover the
entire YFP fluorescence range were created by grouping 35–50 cells distributed around similar YFP fluorescent values (SARAF-YFP, n = 228; control-YFP,
n = 217). The averaged basal Ca2+ levels are plotted as a function of expression groups.
(D) Immunoblot analysis of SARAF, STIM1 and Orai1 expressed in HeLa cells before or after treatment with siSARAF or siGFP (control).
(E) Cytosolic Ca2+ levels of HeLa cells transfected with siSARAF (n = 118) or siGFP (n = 185), and of Jurkat cells (siSARAF, n = 236) (siGFP, n = 247).
(F) Averaged ER Ca2+ measured in individual cells transfected with siSARAF or siControl (nontarget, see Extended Experimental Procedures). ER Ca2+ was
estimated by monitoring the peak of ionomycin-induced Ca2+ released from the ER in the presence of extracellular EGTA (3 mM, inset).
(G) Fluorescent images of a HEK293-T cell expressing SARAF-GFP (green) and STIM1-mCherry (red); the scale bar represents10 mm. (H) Cytosolic Ca2+ levels of
HeLa cells transfected siSARAF (n = 250), si STIM2 (n = 417), siSTIM2+siSARAF (n = 481), or siControl (n = 289). p value: * < 0.05, ** < 0.01, *** < 0.001.faster Ca2+ chelator, 1,2-bis(o-aminophenoxy)ethane-N,N,N’,N’-
tetra-acetic acid (BAPTA) (10 mM), in the pipette solution. Under
these experimental conditions, ICRAC currents were of similarmagnitude for both control and SARAF-expressing cells and
did not undergo inactivation (Figure 2B). These results suggest
that the onset of SARAF-mediated ICRAC inactivation dependsCell 149, 425–438, April 13, 2012 ª2012 Elsevier Inc. 427
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on the presence of free cytosolic Ca2+ ions. To address more
specifically whether ER luminal Ca2+ content affects SARAF-
mediated ICRAC inhibition, we repeated the experimental para-
digm as in Figure 2A with the addition of 2 mM Thapsigargin
(Tg), an irreversible SERCA (sarcoplasmic/endoplasmic retic-
ulum Ca2+-ATPase), in the patch pipette solution. In the absence
of ER Ca2+ refilling, both control and SARAF-expressing cells
exhibited reduced ICRAC inactivation (Figure 2C) compared to
conditions that allow ER Ca2+ refilling (Figure 2A), indicating
that store refilling partially contributes to the inactivation
process. In the absence or presence of Tg, the extent of current
inactivation in control cells was 35.6% ± 3.2% (from Figure 2A)
and 80.6% ± 4.4% of peak levels, respectively. Similar changes
were seen in cells expressing SARAF, with 17.3% ± 1% (from
Figure 2A) and 40% ± 1.6% of peak levels, respectively. These
data suggest that there is a substantial component of ICRAC inac-
tivation that is dependent on luminal Ca2+, which in turn may be
partially modulated by SARAF. In order to further confirm that
SARAF is indeed involved in regulating Ca2+ entry upon ER
Ca2+ depletion, we monitored SOCE-induced [Ca2+]i changes
under conditions that either allowed or prevented ER refilling.
To equilibrate both [Ca2+]cyto and [Ca
2+]ER in control and
SARAF-expressing cells, we incubated cells in a Ca2+-free extra-
cellular solution (1 mM EGTA) (Brandman et al., 2007) for 45 min
prior to the initiation of experiment. Transient ER Ca2+ depletion
was induced by bath application of 100 mM ATP and 100 mM
carbachol (Carb) (Figure 2D). In cells coexpressing Orai1,
STIM1, and SARAF, the rise in [Ca2+]cyto after the addition of
extracellular Ca2+ was about 2-fold lower than in STIM1- and
Orai1-coexpressing cells (Figure 2D). In contrast, under condi-
tions where SOCE activity was induced by Tg, the apparent
ability of SARAF to inhibit SOCE activity was greatly diminished.
It should be noted that a small but persistent difference in
[Ca2+]cyto rise under these conditions was maintained between
SARAF-expressing and control cells (an average of 13.9% ±
2.2% in the relative Rmax value, from seven independent exper-
iments, p < 0.05, t test analysis). The apparent nonlinear correla-
tion between the effects of SARAF on steady-state ICRAC
currents and on [Ca2+]cyto may arise because of the nature of
the recordingmethod, i.e., direct Ca2+ ion flow versus cumulative
determination [Ca2+]cyto with electrophysiology and fluores-
cence Ca2+ imaging, respectively. Nevertheless, to exclude theFigure 2. SARAF Mediates ER Ca2+ Refilling-Dependent Regulation of
(A–C) Normalized whole cell current levels at 100 mV of cells expressing YFP-S
contained (A) 1.2 mM EGTA, SARAF (n = 6), control (n = 9) (B) 10 mMBapta, SARA
control (n = 9).
(D)Mean intracellular Ca2+ traces recorded from individual cells (SARAF, n = 36; co
(0.2 mM).
(E) Analysis of 5-HT3 ionophoric receptor activity (1 mM serotonin) expressed with
HEK293-T; response was triggered by 1 mM of serotonin in the presence of 2 mM
(F) Average CD3-induced SOCE activity in Jurkat T cells transfected with siSARA
(G) Averaged BHQ-induced SOCE response in Jurkat T cells transfected with siSA
siControl (red, n = 44).
(H) Averaged whole cell ICRAC currents at 100 mV recorded from Jurkat T cells
containing 1.2 mM EGTA.
(I) Representative fluorescent images of GFP-NFAT localization in HEK293-T c
SARAF. Arrows indicate cells with nuclear localization and asterisks indicate cyt
(J) Quantitation of GFP-NFAT nuclear localization in transfected cell (as in I) Tg- (n
60–100 cells analyzed in each experiment). p value: * < 0.05, ** < 0.01.possibility that SARAF somehow interfered nonspecifically with
cellular Ca2+ signaling, we monitored the serotonin-dependent
Ca2+ influx through the 5HT3 receptor (5HT3R), in HEK293-T
cells. SARAF expression did not affect 5HT3R-mediated Ca2+
influx and thus a nonspecific effect of SARAF on Ca2+ perme-
ation is ruled out (Figure 2E). To substantiate that indeed SARAF
is playing an important role in regulating SOCE activity under
native conditions, we measured SOCE activity in Jurkat T cells
where endogenous SARAF levels were reduced by siRNA. In
these cells, we performed both transient activation of SOCE
(using anti-CD3) and permanent activation (using Tg) by using
a similar experimental paradigm to that described in Figure 2D
(Figure 2F and Figure S3E). SOCE activation by CD3-induced
store depletion in siSARAF-treated Jurkat cells resulted in pro-
longed elevation of [Ca2+]cyto, whereas control cells exhibited
similar initial Ca2+ elevation, which later decreased to levels
that were about 2-fold lower than in SARAF-silenced cells.
SOCE induction by Tg showed no significant differences
between control and siSARAF-treated cells, which is similar to
the experiments with HEK293 cells (Figure S3E). Similar results
were also obtained from HeLa cells in which SARAF expression
was either elevated via SARAF cDNA expression or reduced by
siSARAF (Figures S3C and S3D), thus emphasizing the ubiqui-
tous nature of SARAF action. To confirm that endogenous
SARAF was indeed the molecular component responsible for
SOCE inactivation, we tested the ability of the murine form of
SARAF (mSARAF), whose mRNA is not targeted by the human
siSARAF used in the above experiments (Figure S2F), to rescue
the SARAF phenotype. Jurkat cells were cotransfected with si-
SARAFwith or without mSARAF cDNA, and SOCEwas activated
by the reversible SERCA inhibitor BHQ (2,5-Di-t-butyl-1,4-ben-
zohydroquinone). mSARAF rescued SOCE inactivation, indi-
cating that SARAF is the molecular component responsible for
SOCE inactivation (Figure 2G and Figures S3F–S3H). Similarly,
recording of ICRAC from Jurkat cells treated with siSARAF also
showed a reduction in current inactivation; in control cells,
currents remaining after 4 min in the presence of high external
Ca2+ were 15.2% ± 5% (n = 15), whereas in siSARAF-treated
cells, currents were 82% ± 4% (n = 9, p < 0.05) (Figure 2H).
Current densities in control and siSARAF-treated Jurkat cells,
however, were similar, with values of 1.35 ± 0.10 pA/pF and
1.17 ± 0.06 pA/pF, respectively.SOCE
TIM1, mCherry-Orai1 with (black) or without SARAF (red). (A) Pipette solutions
F (n = 6), control (n = 8) (B), or (C) 1.2 mMEGTA plus 0.2 mMTg, SARAF (n = 11),
ntrol, n = 46) after activation of SOCE by ATP +Charbachol (100 mMeach) or Tg
(n = 11, black), without SARAF (n = 14, red) or nontransfected (n = 8, green) in
Ca2+.
F (n = 45, black) or nontarget siControl (n = 52, red).
RAF (black, n = 41), siSARAF withmouse-siSARAF (blue, n = 15) and nontarget
treated with siSARAF (black, n = 9) or siControl (red, n = 15). Pipette solutions
ells expressing GFP-NFAT (control), with STIM1/Orai1 or with STIM1/Orai1/
osolic localization of NFAT.
= 2) and BHQ-induced SOCE(n = 6). (n = number of independent experiments,
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Figure 3. SARAF Translocates to ER-PM Regions in a STIM1-Dependent Manner after Store Depletion
(A) Fluorescent images of an HEK293 cell expressing SARAF-GFP, taken under epi illumination or TIRF configurations. Images of the same cell taken after the
application of Tg (0.2 mM) (lower).
(B) TIRF images of a cell expressing SARAF-GFP and STIM1-mCherry before (upper) and after incubation with Tg (lower).
(C) Images of a cell expressing SARAF-GFP and Orai-mCherry, taken under epi illumination, before (upper) and after the application of Tg (lower).
(D) Images of a cell expressing SARAF-GFP, Orai-mCherry treatedwith siSTIM1 and siSTIM2, taken under epi illumination, before (upper) and after the application
of Tg (lower).As an independent third measure for the possible action of
SARAF on SOCE activity, we assessed the ability of SARAF to
interfere with the Ca2+-dependent translocation of the nuclear
factor of activated T cells (NFAT-GFP) to the cell nucleus (Tomida
et al., 2003). In unstimulated cells, coexpressing STIM1 and Orai1
withorwithoutSARAF,NFAT-GFPwaspredominantly found in the
cytoplasm.After ERCa2+depletion byBHQand the reintroduction
of externalCa2+, in cells expressingSTIM1andOrai1, 73%± 2.8%
of the cells exhibited nuclearNFAT-GFP localization, compared to
only 44% ± 3.1% of the cells expressing STIM1, ORAI1, and
SARAF. In contrast, when ER refilling was abolished by Tg, nearly
all cells exhibited nuclear localization of NFAT and the expression
of SARAF no longer made a significant difference (Figures 2I and
2J). The experiments described above indicate that SARAF-medi-
ated SOCE inactivation primarily depends on cytosolic Ca2+ rise
and is partially affected by the ER Ca2+ refilling state.
SARAF Translocates to ER-PM Regions in a
STIM1-Dependent Manner after Store Depletion
One of the most prominent manifestations of STIM1-Orai1-
induced SOCE is the puncta formation of a multimeric STIM1-
Orai1 protein aggregate at specialized ER-PM junctions (Liou
et al., 2005). If SARAF directly inhibits SOCE, it should be found
at these active sites as well. Indeed, in cells coexpressing430 Cell 149, 425–438, April 13, 2012 ª2012 Elsevier Inc.SARAF-GFP together with STIM1-mCherry and Orai1, but not
in cells expressing SARAF-GFP alone, upon depletion of ER
stores with Tg, a significant translocation of SARAF-GFP and
STIM1-mCherry to the plasma membrane was apparent (Fig-
ure 3A–3C and Movie S1). SARAF-GFP translocation into
ER-PM regions did not depend on the [Ca2+]cyto because chela-
tion of free cytosolic Ca2+ did not prevent it (Figure S4D). These
results indicate that ER depletion alone is not sufficient for
SARAF translocation and that either Orai1 or STIM1 were essen-
tial for this process. To test whether endogenous STIM played
a role in the Tg-induced SARAF translocation, we coexpressed
SARAF-GFP andOrai1-mCherry in siSTIM1 and siSTIM2-treated
cells (Figures S4A–S4C) and monitored their cellular localization.
Silencing STIM1 and STIM2 protein levels inhibited the Tg-in-
duced SARAF-GFP translocation in the presence of Orai1-
mCherry (Figure 3D). These results indicate that after store
depletion, SARAF ability to translocate into ER-PM regions
depends primarily on the presence of STIM proteins.
SARAF Luminal Domain Regulates Its Activity
and the Cytosolic Domain Is Responsible
for SOCE Modulatory Function
Full-length human SARAF cDNA encodes a 339 amino acid (aa)
protein that contains a cleavable signal peptide (aa 1–30)
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Figure 4. The ER Luminal Domain of SARAF Regulates Its Activity and the Cytosolic Domain Mediates Its SOCE Inhibitory Activity
(A) Mean intracellular Ca2+ traces of individual HEK293-T cells expressing STIM1+Orai1 alone (n = 46) or with N0 (SARAF(1-191)) (n = 38) or C0 (SARAF(196-339))
(n = 29) termini of SARAF constructs. SOCE was induced by ATP+Charbachol (100 mM each) or Tg (0.2 mM).
(B) Mean normalized whole-cell ICRAC currents (at 100 mV, 1.2 mM EGTA, and 2 mM Tg in the pipette) of cells expressing STIM1 and Orai1 with (black, n = 8) or
without C0-SARAF-GFP (n = 14). Dashed trace is taken from Figure 2C for comparison.
(C) Western blot analysis of input or immune-precipitated material (IP with anti-GFP) prepared from cells expressing Orai1and STIM1 before and after SOCE
induction by Tg, supplemented with purified YFP-SARAF(196-339) or GIRK1(365-501) (negative control) proteins.
(D) Fluorescent images of HEK293-T cells coexpressing YFP-C0-SARAF and mCherry-Orai1 alone or with STIM1. (Lower) TIRF images of a cell expressing
mCherry-Orai1/STIM1/YFP-C0 SARAF after SOCE induction.
(E) Mean intracellular Ca2+ traces of individual HEK293-T cells expressing STIM1+Orai1 alone (red), with SARAF (black), or with SARAF(E148A) mutant (blue).
SOCE was induced with BHQ (2 mM) as indicated.
(F) Quantitation of steady-state SOCE activity (DR) as indicated in (E), data obtained from three independent experiments (15–45 cells each).
(G) Normalized percentage of GFP-NFAT nuclear localization induced by BHQ in cells expressing STIM1/Orai1 alone, with SARAF, or SARAF(E148A). Data
obtained from three independent experiments (60–100 cells each). p values: * < 0.05, ** < 0.01, *** < 0.001.(Zhang and Henzel, 2004) and a single putative transmembrane
domain (aa 173–195). SARAF topology predicts a cytoplasm
facing domain (aa 196–339) and an ER-luminal facing domain
(aa 31–172) (Figure 1A). We cloned an additional splice isoform
of the human SARAF gene, SARAF-S, fromHEK293 cells (acces-
sion number JQ348892). This splice isoform lacks the second
exon of the full-length SARAF and results in a shorter open
reading frame (ORF), corresponding to aa 173–339 (the ORF is
identical to AK315956). The short isoform exhibits similar cellular
distribution and translocates to ER-PM regions after SOCE acti-
vation, similar to the full-length protein (Figure S5A). To elucidate
the potential differential roles played by either the luminal or the
cytosolic domains of SARAF, we created YFP fusions with eitherN-terminal (aa 1–191) or C-terminal (aa 196–339) domains and
tested their ability to regulate SOCE. We repeated the same
experimental paradigm as in Figure 2D and measured SOCE
under both store refilling and nonrefilling conditions. Remark-
ably, truncation of SARAF C-terminal cytosolic domain elimi-
nated SOCE modulation. In contrast, truncation of SARAF
luminal N-terminal domain resulted in strong inhibition of SOCE
that exhibited little dependence on store refilling (Figure 4A).
To further address this issue we measured ICRAC currents in
the absence of store refilling in cells expressing C0-SARAF using
the same experimental conditions as in Figure 2C. Strikingly,
in the absence of store refilling, in cells expressing C0-SARAF
isoform currents inactivated to 20.8% ± 2.8% of peak levels,Cell 149, 425–438, April 13, 2012 ª2012 Elsevier Inc. 431
whereas in control cells the extent of current inactivation was
more than 3-fold lower (64.6% ± 5.2%, Figure 4B). Peak current
densities were similar in both control-expressing (31 ± 1.4 pA/
pF, n = 14) and C0-SARAF- expressing (29 ± 2.3 pA/pF, n = 8)
cells, indicating that SOCE inactivation by the C0-SARAF
remained dependent on cytosolic Ca2+. To test whether the
C0-SARAF interacts directly with STIM1 or Orai1, we performed
immuno-pull down analysis by using purified YFP-C0-SARAF
(aa 196–339) and extracts from HEK293-T cells coexpressing
STIM1 and Orai1-HA. We found that YFP-C0-SARAF mainly
precipitated STIM1; traces of Orai1 immunopercipitate were
also detected, which may be attributed to its native interaction
with STIM1 (Figure 4C). In contrast, similar immuno-pull down
analysis using N0-SARAF-YFP were inconclusive and indicated
a very weak, if any, interaction with STIM1 (Figure S5F). From
the above functional assays, it was expected that C0-SARAF
would colocalize at ER-PM junctions upon store depletion in
a STIM1-dependnet manner. Indeed, cells expressing both
YFP-C0-SARAF and mCherry-Orai1 exhibited dispersed cyto-
solic staining that did not overlap with that of mCherry-Orai1
(Figure 4D). In contrast, when STIM1 was also coexpressed,
YFP-C0-SARAF could be found in reticular structures that moved
close to plasma membrane regions upon store depletion to form
the classical puncta as described in Figure 3B (see also Fig-
ure 4D). The reticular like structures of YFP-C0-SARAF colocal-
ized with STIM1-mCherry, and formation of these structures
did not require Orai1 (Figures S5C–S5E). Taken together, the
above results suggests that the SARAF C-terminal domain
recognizes a domain on STIM1 that enables it to control SOCE
activity, whereas the luminal N-terminal domain is responsible
for the regulation of SARAF inhibitory activity. To further test
this hypothesis, we mutated a conserved glutamate (E148) in
the N-terminal region of SARAF and tested its effect on SARAF
activity. SARAF(E148A) dominantly inactivated SARAF pheno-
typic activity both on SOCE and on NFAT translocation (Figures
4E–4G), similar to the phenotype seen after its silencing with
siRNA. Moreover, the SARAF(E148A)-YFP mutant exhibited
normal translocation into Orai1 puncta at ER-plasma membrane
junctions upon store depletion (Figure S5B).
SARAF Associates with STIM1 at Rest
To further test the mode of interaction between SARAF and
STIM1, we coexpressed SARAF-GFP and STIM1-mCherry and
used a FRET (Fo¨rster resonance energy transfer)-based
approach to test for intermolecular interactions between the
two proteins. Remarkably, resting cells without SOCE stimula-
tion, exhibited a significant FRET signal between SARAF-GFP
and STIM1-mCherry. The specificity of this signal was validated
in several ways. First, to check for random collisions that may
occur between the two constructs, we replaced the donor
SARAF-GFP with a cytosolic expressed GFP. Under these
conditions, no FRET could be detected between GFP and
STIM1-mCherry (Figures 5A and 5B). Next, to test whether true
donor and acceptor interactions were responsible for the FRET
signal within the oligomer, we coexpressed SARAF-GFP with
STIM1-mCherry and added untagged SARAF to compete with
SARAF-GFP on STIM1-mCherry binding. Adding untagged
SARAF resulted in a decrease in the FRET signal between432 Cell 149, 425–438, April 13, 2012 ª2012 Elsevier Inc.SARAF-GFP and STIM1-mCherry (Figure 5C). Likewise, the
reverse competition with untagged STIM1, underlining the
specific interaction between the twomolecules. Finally, acceptor
photobleaching was used to verify that indeed, destruction of the
acceptor dequench donor fluorescence (Figures S6A and S6B)
(Riven et al., 2003). Furthermore, independent measurements
of FRET were also obtained using the time-domain approach,
by measuring fluorescent donor life-time changes, fluorescence
lifetime imaging microscopy (FLIM) (Raveh et al., 2010) (Figures
S6C–S6F). These measurements verified our initial observation
and confirmed that STIM1 and SARAF interact at rest. We then
measured FRET changes during SOCE activation after the appli-
cation of a combination of ATP, Carb, and Tg to cells that
express SARAF-GFP and STIM1-mCherry in the presence or
absence of Orai1. Remarkably, about a 20% FRET change in
the mCherry/GFP ratio was observed only in cells that contained
both STIM1 andOrai1 (Figure 5D). The increase in FRET between
STIM1 and SARAF after store depletion was reversible when
the stores were allowed to refill (Figures S6E and S6F). These
results indicate that SARAF and STIM1 associate under resting
conditions and that SOCE activation promotes molecular rear-
rangements between STIM1 and SARAF C termini in an Orai1-
dependent manner.
SARAF Inhibits Spontaneous Activation of STIM1
In order to study the functional consequences of STIM1 and
SARAF interaction under resting conditions, we silenced endog-
enous SARAF expression and analyzed STIM1 and Orai1 activity
and distribution. In control cells under resting conditions, we
observed a reticular staining pattern for YFP-STIM1 that was
also evident, in part, near plasma membrane regions with a
uniform Orai1-mCherry plasma membrane staining. After ER
depletion, this morphology changed into intense colocalized
punctate fluorescence signals from both YFP-STIM1 and
Orai1-mCherry at plasma membrane regions (Figure 6A). When
cells where endogenous SARAF expression was reduced were
at rest, YFP-STIM1 fluorescence near the plasma membrane
was significantly increased with both STIM1-YFP and Orai1-
mCherry forming fluorescent puncta (Figure 6A). After the
depletion of Ca2+ from the ER by Tg, a smaller additional recruit-
ment of YFP-STIM1 into puncta was apparent but with an overall
effect that was similar to control cells under similar conditions.
To test the functional consequences of this effect on SOCE,
we measured NFAT translocation and [Ca2+]cyto levels under
similar conditions. Basal [Ca2+]cyto was significantly elevated in
siSARAF-treated cells, a difference that could be reversed by
either rescuing SARAF expression by mSARAF or by omitting
external Ca2+ from the incubation medium (Figure 6C). In agree-
ment with the increased basal SOCE, enhanced nuclear localiza-
tion of NFAT was also observed in siSARAF-treated cells under
either basal conditions or after reversal depletion of the stores
(Figure 6D).
SARAF Enhances STIM1 Deoligomerization upon Store
Refilling
To gain further insight into the mechanism by which SARAF
modulates SOCE, we raised the question whether STIM1-
STIM1 oligomeric interactions that underlie SOCE activation
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Figure 5. Resting and Dynamic Interaction of SARAF with STIM1
(A and B) Fluorescent images of HEK293-T cells expressing STIM1-mCherry together with GFP (A) or with SARAF-GFP (B). Images are of the same field in
both GFP and mCherry channels acquired simultaneously. Fluorescent signals in the mCherry channel result specifically from FRET between SARAF-GFP and
STIM1-mCherry (B).
(C) Quantitation of mCherry and GFP fluorescence levels and mCherry/GFP ratios measured from individual cells expressing STIM1-mCherry and SARAF-GFP
(n = 232), alone or with untagged STIM1 (n = 120) or SARAF (n = 86).
(D) Time course of mean mCherry/GFP ratios measured from individual cells expressing STIM1-mCherry and SARAF-GFP alone (red, n = 18) or with Orai1
(black, n = 44) after the application of ATP, Carb (100 mM each) and Tg (0.2 mM). p value: ** < 0.01.and inactivation, are affected by the presence of SARAF. For this
purpose, we expressed STIM1-GFP, STIM1-mCherry, and Orai1
with or without SARAF and monitored the dynamics of FRET
signals between STIM1-GFP/mCherry during ER Ca2+ depletion
and refilling. In agreement with previous studies (Liou et al.,
2007), we observed an increase in FRET after ER Ca2+ depletion
and a subsequent decrease after ER Ca2+ refilling. In both
control and SARAF overexpressing cells, the rate of FRET
increase during ER Ca2+ depletion and decrease after refilling
were similar. With or without SARAF after ER refilling, the time
constants of FRET decrease were 11.9*103 ± 0.6*103%/s
and 12.9*103 ± 0.7*103%/s, respectively. In contrast, the
extent to which the FRET signal was decreased was different,
possibly reflecting a reduced amount of STIM1 oligomers in
the presence of SARAF (Figure 7A). Because the extent of ER
Ca2+ refilling mirrors the oligomeric state of STIM1 (Shen et al.,
2011), these results are in apparent contradiction with reduced
ICRAC monitored in SARAF-expressing cells. To test this theoret-
ical discrepancy, we determined the levels of ER Ca2+ levels
under the same experimental conditions as in Figure 7A. Results
from this analysis indicated that in agreement with reduced ICRAC
and prior to the onset of the STIM1 deoligomerization process,
[Ca2+]ER was stabilized at lower levels in cells overexpressingSARAF compared to the levels in control cells (Figure 7B). In
conclusion, these results indicate that SARAF reduces active
STIM1 oligomers upon Ca2+ entry and store refilling even at
lower [Ca2+]ER (Figures 7C and 7D).
DISCUSSION
By screening for genes that shape mitochondrial Ca2+ levels, we
serendipitously identified SARAF as a regulator of store operated
calcium influx. Increasing or decreasing SARAF expression
levels resulted in opposite effects on global levels of intracellular
Ca2+ at resting and activated states, indicating an important role
for this gene product in the regulation of cellular Ca2+ homeo-
stasis. SARAF shares similar topology and overall structure-
function relationships with STIM proteins and consists of a single
pass ER membrane protein with a cytosolic facing segment
responsible for activity, whereas its luminal facing segment
engages in regulatory function. Moreover, like STIM1, SARAF
also contains a serine-proline rich domain followed by a cluster
of basic residues at its C-terminal tail that may aid its interaction
with the plasma membrane phospholipids (Huang et al., 2006;
Korzeniowski et al., 2009; Park et al., 2009) (Figure 1A). Whether
this similarity bears functional significance is currently unclear;Cell 149, 425–438, April 13, 2012 ª2012 Elsevier Inc. 433
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(A) Representative TIRF images of cells treated with siSARAF or siControl, before and after treatment with Tg (bottom).
(B) Quantitation cell surface puncta formed by STIM1-YFP andmCherry-Orai1 in cells treated with siSARAF (n = 24) or with siControl (n = 25), before and after the
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(C) Average of intracellular Ca2+ traces of HeLa cells transfected with siSARAF (n = 20), siSARAF+cDNA of mSARAF (n = 38) and siControl (n = 30).
(D) Summary of nuclear localization of GFP-NFAT in siControl or siSARAF-treated cells, before and after BHQ application. Data obtained from three independent
experiments, 60–100 cells each. p value: * < 0.05.however, our results strongly suggest that STIM is the major
target for SARAF regulation. This conclusion is supported by
several lines of evidence, as both proteins colocalize to the
same organelle where they reside within a short distance from
each other (5–10 nm) and undergo dynamic physical interaction
in response to Ca2+ store depletion. The results presented in this
work, however, do not rule out additional functional interaction
between SARAF and Orai1, and further studies are needed to
address this point.
SARAF is expressed in theERmembrane and regulates cellular
Ca2+ influx mediated by STIM1 activation of Orai1. SARAF regu-
lation over SOCE, however, is largely dependent on Ca2+ entry.
The robust ability and the nature bywhich SARAF regulates ICRAC
currents is in favor of the idea that SARAF may be part of the
molecular entity responsible forone formof slowCa2+-dependent
inactivation process that was previously identified in cultured
cells and native tissues (Louzao et al., 1996; Parekh, 1998;
Zweifach and Lewis, 1995). Previous studies that analyzed slow
Ca2+-dependent inactivation of ICRAC yielded somewhat different
findings. In rat basophilic leukemia (RBL) cells inactivation onset
depended on cytosolic Ca2+, but no appreciable involvement of
store refilling was observed. In Jurkat cells, however, a strong434 Cell 149, 425–438, April 13, 2012 ª2012 Elsevier Inc.dependence on cytosloic Ca2+ for CRAC channel inactivation
was also reported, but about 50% of inactivation was traced to
the refilling of stores. Similar to the findings in both studies
mentioned above, we find that the onset of CRAC channel inacti-
vation mediated by SARAF critically depends on cytoslic Ca2+.
Involvement of store refilling, however, is only apparent with the
full-length SARAF but not with its short splice isoform. Moreover,
we find that the depletion of SARAF expression in Jurkat T cells
also diminishes ICRAC inactivation (Figure 2H). It is therefore
conceivable that differential cell-specific alternative splicing of
SARAF may explain some of the discrepancies observed in
previous studies and thus may also underlie a mechanism for
regulating cell Ca2+ homeostasis at the posttranscriptional level.
The precise molecular mechanism that underlies the ability of
SARAF to sense cytosolic Ca2+ elevations and induce ICRAC inac-
tivation is unclear at this stage. Recently, via a proteomics
approach, a modulator for SOCE activity, an EF-hand containing
a cytosolic protein termed CRACR2A, was identified (Srikanth
et al., 2010). CRACR2A binds both Orai1 and STIM1 to aid the
stabilization of the active CRAC complexes, mainly under condi-
tions of low abundance of STIM1 and Orai1. Upon the elevation
of cytosolic Ca2+, CRACR2A is believed to dissociate from the
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(A) Time course of mean GFP/mCherry FRET signal measured from individual cells expressing Orai1, STIM1-mCherry and STIM1-GFP alone (n = 41) or with
SARAF (n = 21). SOCE was induced by ATP, Carb (100 mM each) and BHQ (2 mM).
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(n = 189), SOCE induction like in (A) and store refilling by the application of 2 mM Ca2+.
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the cell with excessive Ca2+ ions. Events read left to right.complex to promote the destabilization of the SOCE complex.
Like SARAF it also responds to local elevation of Ca2+ near the
plasma membrane. It remains to be seen if CRACR2A has a cor-
responding effect on ICRAC. Whether the two proteins are part of
the same protein complex that regulates CRAC channels is an
appealing possibility that awaits future studies.
The ER luminal facing segment of SARAF regulates the inhibi-
tory action mediated by the cytosolic facing segment, which has
the capability to interact with the C-terminal cytosolic domain of
STIM1. The apparent action of SARAF in facilitatingERCa2+ refill-
ing-dependent inactivation is, however, likely a consequence of
its ability to indirectly respond to changes in [Ca2+]ER and
promote anefficient disaggregation of STIMmolecules (Figure 7).
The regulatory role of the SARAF ER luminal facing domain is
underlined by the enhanced ability of the short isoform of SARAF
to inhibit ICRAC independently of store refilling. The fact that
a mutation in this region has a dominant negative effect on
SOCE activity also suggests that SARAF may be functional as
a dimer or in a higher-order complex. The ER luminal facing
segment of SARAF, however, does not show clear similarity
with any known Ca2+ binding motifs. In addition, ICRACmeasure-
ments in the absence or presence of store refilling yield similar2-fold differences in both control and SARAF-expressing cells
(Figures 2A and S2C), and translocation of SARAF to ER-PM
regions depends on that of STIM1 but not on store depletion
per se (Figure 3). It is therefore less likely that SARAF directly
binds Ca2+ ions and thus raises the possibility that SARAF may
respond to changes in [Ca2+]ER indirectly through interaction
with STIM or other ER Ca2+-sensitive proteins or is regulated
by other physiological mechanisms (Enyedi et al., 2010; Hawkins
et al., 2010). The functional interaction of SARAFwith STIM1may
point toward the former possibility, were coupling between
STIM1 Ca2+ occupancy and the SARAF inhibitory mode, found
to occur. Such a scenario is in agreement with spontaneous acti-
vation of STIM1 proteins without ER Ca2+ depletion, observed
after knockdown of SARAF expression or with a more efficient
disaggregation and stabilization of inactive STIM1 proteins at
lower ER Ca2+ levels, after an increase in SARAF expression.
The directmode bywhich SARAF affects SOCE inactivation after
ERCa2+ refilling is currently unresolved andawaits future studies.
Although no direct evidence provided to date shows that
mutations in SARAF are linked to any disease state in humans,
studies employing various differential expression or transcrip-
tome-profiling strategies have recently identified SARAF as aCell 149, 425–438, April 13, 2012 ª2012 Elsevier Inc. 435
biomarker linked to prostate cancer (Romanuik et al., 2009a),
Alzheimer’s disease (Twine et al., 2011), and dilated cardiomy-
opathy (DCM) (Camargo and Azuaje, 2008). Notably, most of
these disease states are accompanied by abnormal intracellular
Ca2+ handling. It is also interesting to note that both STIM1 and
SARAF transcripts have been shown to be positively modulated
by androgens, implying common regulatory mechanisms of
these genes expression levels (Berry et al., 2011; Romanuik
et al., 2009b).
In summary we have identified the gene product of TMEM66,
SARAF, as a regulator of store operated calcium entry. SARAF
promotes slow ICRAC inactivation after Ca
2+ entry and refilling
of the endoplasmic reticulum. This physiological role places
SARAF as a dominant player in a protective mechanism de-
signed to prevent rapid overfilling of cells with Ca2+ ions.EXPERIMENTAL PROCEDURES
Fluorescent Measurements of Intracellular Ions
Typically, 6–8 hr after plasmid transfection and 17–24 hr before starting the
experiments, cells were plated onto 24 mm cover glass coated with L-polyly-
sine. On the day of the experiments, the cover glass was mounted on an
imaging chamber and washed with Ringer solution. Fura-2 loading of cells
was performed as previously described (Palty et al., 2010). Cytosolic Ca2+
levels were recorded from fura-2 loaded cells, excited at wavelengths of
340/20 and 380/20 nm and imaged with 510/80 nm filters.
Mitochondrial Ca2+ levels were monitored in cells expressing the mitochon-
drial-targeted ratiometric-pericam (RP-mt) protein via excitation wavelengths
of 436/20 nm and 480/20 nm and emission collected with a 540/80 nm filter.
Endoplasmic reticulum Ca2+ levels were recorded in cells expressing D1ER
via a dual view device with a CFP/YFP filter set.
All experiments were conducted with Ringer’s solutions containing 130 mM
NaCl, 20 mM HEPES,15 mM Glucose, 5 mM KCl, and 0.8 mM MgCl2 with the
pH adjusted to 7.4. Ringer’s solution was supplemented with 2 mM CaCl2 or
1 mM EGTA (Ca2+ free) as indicated. For all single cell imaging experiments,
traces of averaged responses, recorded from 10 to 50 cells in each experi-
ment, were plotted with KaleidaGraph. All experiments were repeated 2 to
8 times. Statistical significance was determined with t test analysis; p < 0.05
was considered significant. All data are shown as average ± SEM.NFAT Translocation Assay
Monitoring of nuclear translocation of NFAT-GFP was performed 30–48 hr
posttransfection in HEK293-T or HeLa cells. At the start of each experiment,
cells were washed twice with Ca2+-free Ringer’s solution, and 2 mM BHQ or
0.2 mM Tg were added for 5 min. Cells were then washed with Ca2+-free
Ringer’s solution for additional 5 min and incubated for 30 min in a 2 mM
Ca2+-containing Ringer’s solution. Localization of NFAT-GFP in cells was
examined by fluorescent microscopy before and after SOCE induction.Electrophysiological Recordings
Recorded HEK293-T or HEK293 cells were transfected 24–36 hr prior to
electrophysiology experiments. Each transfection contained STIM1 and
Orai1 with or without SARAF (1 mg each). Cells were transferred to the
measurement chamber more than 6 hr before measurements for HEK293 cells
and 10–20 min for Jurkat cells. Membrane currents were recorded under
voltage-clamp conditions with whole-cell variation of the patch-clamp config-
uration by using Axopatch 200B (Axon Instruments). Patch pipettes were
fabricated from borosilicate glass capillaries (2–5 MU). Signals were analog
filtered with a 1 kHz low-pass Bessel filter. Data acquisition and analysis
were done with pCLAMP 9 software (Axon Instruments). All data were leak-
corrected with the current elicited in Ca2+-free Ringer’s solution at the begin-
ning of each experiment. More detailed information and solutions used are
in Extended Experimental Procedures.436 Cell 149, 425–438, April 13, 2012 ª2012 Elsevier Inc.ACCESSION NUMBERS
The GeneBank accession number for SARAF is JQ348891, and for SARAF
short isoform it is JQ348892.SUPPLEMENTAL INFORMATION
Supplemental Information includes Extended Experimental Procedures,
six figures, and one movie and can be found with this article online at
doi:10.1016/j.cell.2012.01.055.
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